Identification of two pathogenic mutations in SORL1 in early-onset Alzheimer's disease.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Guozhen QiuChunyan Xu

Abstract

The sortilin-related receptor 1 (SORL1) gene has been the subject of many studies focusing on frequent polymorphisms, which is associated with increased risk for Alzheimer's Disease (AD). By whole-exome sequencing (WES), we identified two pathogenic missense mutations c.579C > G (p.F193L) and c.1397A > G (p.N466S) in SORL1. The two mutations were located in the same protein domain, and the two unrelated probands both had an onset of memory problems at less than 65 years of age, but their clinical manifestations and cranial imaging are different. The protein structure and function affected by these mutations were predicted using bioinformatics analysis, which suggested they were pathogenic. 3D protein structural analysis revealed that these amino acid substitutions might result in instability of protein structure and adverse intramolecular interactions. These findings suggest that both F193L and N466S should be thought as potential causative mutations in early-onset Alzheimer's disease (EOAD) patients. Further functional studies are warranted to evaluate their roles in the pathogenesis of AD.

References

Jul 18, 2006·Nucleic Acids Research·Vijaya ParthibanDietmar Schomburg
Dec 8, 2007·Neurobiology of Aging·E K TanW L Lee
Apr 8, 2009·Genome Medicine·Peter D StensonDavid N Cooper
May 13, 2009·Cellular and Molecular Life Sciences : CMLS·Guido Hermey
Dec 17, 2009·Cell·Alexandra K GardinoDorothee Kern
Sep 14, 2011·Archives of Neurology·Thomas S WingoDavid J Cutler
Feb 9, 2012·PloS One·Carlos CruchagaUNKNOWN NIA-LOAD/NCRAD Family Study Consortium
Mar 1, 2012·Bioinformatics·Konstantin OkonechnikovUNKNOWN UGENE team
Apr 5, 2012·Molecular Psychiatry·C PottierUNKNOWN PHRC GMAJ Collaborators
Feb 14, 2014·Science Translational Medicine·Safak CaglayanThomas E Willnow
Nov 11, 2014·Annals of Neurology·Badri N VardarajanRichard Mayeux
Feb 3, 2015·Nature Structural & Molecular Biology·Yu KitagoJunichi Takagi
Nov 20, 2015·Nucleic Acids Research·Melissa J LandrumDonna R Maglott
Mar 27, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Rita CacaceChristine Van Broeckhoven
Oct 22, 2016·Acta Neuropathologica·Olav M AndersenThomas E Willnow
Nov 11, 2016·Cellular and Molecular Life Sciences : CMLS·Vanessa SchmidtThomas E Willnow
May 26, 2017·European Journal of Human Genetics : EJHG·Henne HolstegePhilip Scheltens
Dec 5, 2017·Journal of Alzheimer's Disease : JAD·Morgan RobinsonFrancis T Hanes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.